STOCK TITAN

Inhibrx director trust buys 5,000 INBX shares

Inhibrx Biosciences, Inc. (INBX) director Jon Faiz Kayyem reported an open-market purchase of 5,000 shares of common stock on September 16, 2026 at $100 per share, made indirectly through The Jon F. Kayyem and Paige Gates-Kayyem Family Trust.

(High)
(Positive)
Form Type
4

Rhea-AI Filing Summary

Inhibrx Biosciences, Inc. (INBX) director Jon Faiz Kayyem reported an open-market purchase of 5,000 shares of common stock on September 16, 2026 at $100 per share, made indirectly through The Jon F. Kayyem and Paige Gates-Kayyem Family Trust. Following this transaction, that trust holds 429,360 shares. Additional indirect holdings reported include 250,000 shares held by the Jon Faiz Kayyem Revocable Trust, 250,000 shares held by the Paige Gates-Kayyem Revocable Trust, and 69,843 shares held in a custodial account for each of two minor children, for which the reporting person disclaims beneficial ownership in certain cases except to the extent of any indirect pecuniary interest.

Positive

  • None.

Negative

  • None.

Insights

Analyzing...

Insider Kayyem Jon Faiz
Role Director
Bought 5,000 shs ($500K)
Type Security Shares Price Value
Purchase Common Stock F1 5,000 $100.00 $500K
holding Common Stock F2 -- -- --
holding Common Stock F3 -- -- --
holding Common Stock F4 -- -- --
holding Common Stock F5 -- -- --
Holdings After Transaction: Common Stock — 429,360 shares (Indirect, By The Jon F. Kayyem and Paige Gates-Kayyem Family Trust); Common Stock — 250,000 shares (Indirect, By Jon Faiz Kayyem Revocable Trust); Common Stock — 250,000 shares (Indirect, By Paige Gates-Kayyem Revocable Trust); Common Stock — 69,843 shares (Indirect, By Child A); Common Stock — 69,843 shares (Indirect, By Child B)
Footnotes (5)
  1. F1. These securities are directly owned by The Jon F. Kayyem and Paige Gates-Kayyem Family Trust. Jon Faiz Kayyem is the trustee of The Jon Faiz Kayyem and Paige N. Gates Family Trust and he disclaims beneficial ownership of these securities, except to the extent of any indirect pecuniary interest in his distributive shares therein.
  2. F2. These securities are directly owned by the Jon Faiz Kayyem Revocable Trust, of which Jon Faiz Kayyem is the trustee.
  3. F3. These securities are directly owned by the Paige-Gates Kayyem Revocable Trust, of which Jon Faiz Kayyem's spouse is the trustee.
  4. F4. These securities are directly owned by a custodial account managed by the reporting person for the benefit of the reporting person's minor child, Child A. The reporting person disclaims beneficial ownership of these securities, except to the extent of any indirect pecuniary interest in his distributive shares therein.
  5. F5. These securities are directly owned by a custodial account managed by the reporting person for the benefit of the reporting person's minor child, Child B. The reporting person disclaims beneficial ownership of these securities, except to the extent of any indirect pecuniary interest in his distributive shares therein.
Shares purchased 5,000 shares of common stock Indirect open-market or private purchase on September 16, 2026
Purchase price per share $100.00 per share Price for the 5,000-share purchase on September 16, 2026
Family Trust holdings after transaction 429,360 shares Common stock held by The Jon F. Kayyem and Paige Gates-Kayyem Family Trust after the purchase
Jon Faiz Kayyem Revocable Trust holdings 250,000 shares Common stock held indirectly via the Jon Faiz Kayyem Revocable Trust as of September 16, 2026
Paige Gates-Kayyem Revocable Trust holdings 250,000 shares Common stock held indirectly via the Paige Gates-Kayyem Revocable Trust as of September 16, 2026
Child A custodial account holdings 69,843 shares Common stock held in a custodial account for Child A, with certain beneficial ownership disclaimed
Child B custodial account holdings 69,843 shares Common stock held in a custodial account for Child B, with certain beneficial ownership disclaimed
beneficial ownership financial
"The reporting person disclaims beneficial ownership of these securities, except to the extent of any indirect pecuniary interest"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
indirect pecuniary interest financial
"except to the extent of any indirect pecuniary interest in his distributive shares therein"
Revocable Trust financial
"These securities are directly owned by the Jon Faiz Kayyem Revocable Trust"
A revocable trust is a legal arrangement where the person who creates it keeps control and can change or cancel the trust at any time, while naming who will manage and receive the assets later. Think of it like a flexible folder for your investments and property that can be relabeled or reworked as circumstances change; it matters to investors because it determines how ownership is recorded, how easily assets transfer on incapacity or death, and whether holdings bypass public probate proceedings.
custodial account financial
"These securities are directly owned by a custodial account managed by the reporting person"
A custodial account is an investment or bank account opened and managed by an adult (the custodian) for the benefit of someone who cannot legally control assets, typically a minor. Think of it as a wallet held by a trusted guardian until the beneficiary reaches a legal age: it lets you save and invest on someone’s behalf, affects who makes decisions and who pays taxes, and determines when control of the assets transfers to the beneficiary—details investors watch for tax consequences, ownership rules, and timing of control.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did INBX director Jon Faiz Kayyem report?

He reported an indirect purchase of 5,000 shares of Inhibrx Biosciences common stock on September 16, 2026, executed through The Jon F. Kayyem and Paige Gates-Kayyem Family Trust.

At what price were the INBX shares purchased in this Form 4 filing?

The filing states that 5,000 INBX shares were purchased at $100 per share on September 16, 2026 in an open-market or private transaction by the family trust associated with director Jon Faiz Kayyem.

How many INBX shares does the family trust hold after the reported purchase?

After the September 16, 2026 transaction, The Jon F. Kayyem and Paige Gates-Kayyem Family Trust holds 429,360 shares of Inhibrx Biosciences common stock, as reported in the Form 4 filing.

What other indirect INBX holdings are reported for Jon Faiz Kayyem?

The Form 4 lists 250,000 shares held by the Jon Faiz Kayyem Revocable Trust, 250,000 shares held by the Paige Gates-Kayyem Revocable Trust, and 69,843 shares in a custodial account for each of two minor children.

Does this INBX Form 4 indicate trades under a Rule 10b5-1 trading plan?

No. The filing’s Rule 10b5-1 checkbox is not marked as an affirmative plan, and the footnotes do not state that the 5,000-share purchase or related holdings were made pursuant to a Rule 10b5-1 or similar pre-arranged trading plan.

How does Jon Faiz Kayyem describe his beneficial ownership of certain INBX holdings?

For shares held by the family trust and the custodial accounts for two minor children, the reporting person disclaims beneficial ownership except to the extent of any indirect pecuniary interest in his distributive shares, as stated in the footnotes.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Kayyem Jon Faiz

(Last)(First)(Middle)
C/O INHIBRX BIOSCIENCES, INC.
11025 NORTH TORREY PINES ROAD, SUITE 140

(Street)
LA JOLLA CALIFORNIA 92037

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Inhibrx Biosciences, Inc. [ INBX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/16/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock09/16/2026P5,000A$100429,360IBy The Jon F. Kayyem and Paige Gates-Kayyem Family Trust(1)
Common Stock250,000IBy Jon Faiz Kayyem Revocable Trust(2)
Common Stock250,000IBy Paige Gates-Kayyem Revocable Trust(3)
Common Stock69,843IBy Child A(4)
Common Stock69,843IBy Child B(5)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. These securities are directly owned by The Jon F. Kayyem and Paige Gates-Kayyem Family Trust. Jon Faiz Kayyem is the trustee of The Jon Faiz Kayyem and Paige N. Gates Family Trust and he disclaims beneficial ownership of these securities, except to the extent of any indirect pecuniary interest in his distributive shares therein.
2. These securities are directly owned by the Jon Faiz Kayyem Revocable Trust, of which Jon Faiz Kayyem is the trustee.
3. These securities are directly owned by the Paige-Gates Kayyem Revocable Trust, of which Jon Faiz Kayyem's spouse is the trustee.
4. These securities are directly owned by a custodial account managed by the reporting person for the benefit of the reporting person's minor child, Child A. The reporting person disclaims beneficial ownership of these securities, except to the extent of any indirect pecuniary interest in his distributive shares therein.
5. These securities are directly owned by a custodial account managed by the reporting person for the benefit of the reporting person's minor child, Child B. The reporting person disclaims beneficial ownership of these securities, except to the extent of any indirect pecuniary interest in his distributive shares therein.
Remarks:
/s/ Kelly Deck, as attorney-in-fact to Jon Faiz Kayyem09/17/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading